Three months of weekly rifapentine plus isoniazid for TB prevention among people with HIV
BACKGROUND: Evidence on implementation of three months of weekly isoniazid (H, INH) and rifapentine (P, RPT) (3HP) as a TB preventive therapy (TPT) for at-risk groups in Indian programmatic conditions is limited. METHODS: A prospective demonstration study assessing scale-up, safety, and effectivenes...
Saved in:
Main Authors: | R. Borse, B. Randive, S. Mattoo, P. Malik, H. Solanki, A. Gupta, R.E. Chaisson, V. Mave, N. Suryavanshi |
---|---|
Format: | Article |
Language: | English |
Published: |
International Union Against Tuberculosis and Lung Disease (The Union)
2024-09-01
|
Series: | IJTLD Open |
Subjects: | |
Online Access: | https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000009/art00005 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
3HP preventive treatment among children and adolescents with HIV and child household contacts of TB patients
by: A. Kinikar, et al.
Published: (2024-09-01) -
Children and providers’ perspectives on once-weekly rifapentine and isoniazid TB preventive therapy
by: A.J. Marthinus, et al.
Published: (2025-01-01) -
Mapping TB incidence across districts in Uganda to inform health program activities
by: N.J. Henry, et al.
Published: (2024-05-01) -
TB prevention activities in the WHO European Region
by: A. Matteelli, et al.
Published: (2024-08-01) -
Acceptability of levofloxacin dispersible and non-dispersible tablet formulations in children receiving TB preventive treatment
by: D. T. Wademan, et al.
Published: (2024-02-01)